Cargando…
Factors Influencing the Placebo Effect in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: An Analysis of Two Randomized Clinical Trials
OBJECTIVE: To explore factors related to the placebo effect in patients with primary open-angle glaucoma (POAG) or ocular hypertension (OH). METHODS: This was a retrospective cohort study of patients with POAG and patients with OH who were treated with placebo. The patients’ data were extracted from...
Autores principales: | Kawamura, Taichi, Sato, Izumi, Kawakami, Koji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890934/ https://www.ncbi.nlm.nih.gov/pubmed/27254076 http://dx.doi.org/10.1371/journal.pone.0156706 |
Ejemplares similares
-
Travoprost in the management of open-angle glaucoma and ocular hypertension
por: Denis, Philippe, et al.
Publicado: (2007) -
Tafluprost for the Reduction of Interocular Pressure in Open Angle Glaucoma and Ocular Hypertension
por: Schultz, Clyde
Publicado: (2011) -
Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
por: Araie, Makoto, et al.
Publicado: (2021) -
Outcome of Selective Laser Trabeculoplasty in Young Patients with Primary Open-Angle Glaucoma and Ocular Hypertension
por: Liu, Dan, et al.
Publicado: (2020) -
MLIP genotype as a predictor of pharmacological response in primary open-angle glaucoma and ocular hypertension
por: Canut, María I., et al.
Publicado: (2021)